Pregnancy and Antiphospholipid Syndrome

Seminars in Thrombosis and Hemostasis

Volumn 42, Issue 7, 2016, Pages 780-788

  Schreiber, Karen ^a,b   Hunt, Beverley J ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b Rigshospitalet   (Denmark)

Author keywords

antiphospholipid antibodies; antiphospholipid syndrome; pregnancy; thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; HEPARIN; HYDROXYCHLOROQUINE; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PLACEBO;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; COUNSELING; FETUS WASTAGE; HUMAN; LOW DRUG DOSE; MULTICENTER STUDY (TOPIC); PATHOGENESIS; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT ABORTION; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; THROMBOSIS; BLOOD; COMPLICATION; FEMALE; FETAL GROWTH RETARDATION; PLACENTA DISEASES; PRE-ECLAMPSIA; PREMATURE BIRTH;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYDROXYCHLOROQUINE; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH;

EID: 84988649435     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0036-1592336     Document Type: Article

References (89)

1. Wilson W A Gharavi A E Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop Arthritis Rheum 1999 42 7 1309 1311
2. Miyakis S Lockshin M D Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 2006 4 2 295 306
3. Harris E N Syndrome of the black swan Br J Rheumatol 1987 26 5 324 326
4. Cervera R Piette J C Font J, et al; Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum 2002 46 4 1019 1027
5. Levine J S Branch D W Rauch J The antiphospholipid syndrome N Engl J Med 2002 346 10 752 763
6. Rai R S Regan L Clifford K, et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach Hum Reprod 1995 10 8 2001 2005
7. Cervera R Serrano R Pons-Estel G J, et al; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients Ann Rheum Dis 2015 74 6 1011 1018
8. Espinosa G Cervera R Current treatment of antiphospholipid syndrome: lights and shadows Nat Rev Rheumatol 2015 11 10 586 596
9. Erkan D Aguiar C L Andrade D, et al. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends Autoimmun Rev 2014 13 6 685 696
10. Sciascia S Hunt B J Talavera-Garcia E Lliso G Khamashta M A Cuadrado M J The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies Am J Obstet Gynecol 2016 214 2 273.e1 273.e8
11. Mekinian A Lazzaroni M G Kuzenko A, et al; SNFMI and the European Forum on Antiphospholipid Antibodies. The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study Autoimmun Rev 2015 14 6 498 502
12. Schreiber K SS Breen K Jacobsen S, et al. HYPATIA-A prospective randomised controlled trial of HYdroxychloroquine versus placebo during Pregnancy in women with AnTIphospholipid Antibodies ISTH 2015
13. Brownfoot F C Tong S Hannan N J Hastie R Cannon P Kaitu'u-Lino T J Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta BMC Pregnancy Childbirth 2016 16 117
14. Shi W Krilis S A Chong B H Gordon S Chesterman C N Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population Aust N Z J Med 1990 20 3 231 236
15. Jeleniewicz R Majdan M Targońska-Stępniak B Dryglewska M Prevalence of antiphospholipid antibodies in rheumatoid arthritis patients and relationship with disease activity Pol Arch Med Wewn 2012 122 10 480 486
16. Mok C C Tang S S To C H Petri M Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups Arthritis Rheum 2005 52 9 2774 2782
17. Out H J Bruinse H W Christiaens G C, et al. Prevalence of antiphospholipid antibodies in patients with fetal loss Ann Rheum Dis 1991 50 8 553 557
18. de Groot P G Lutters B Derksen R H Lisman T Meijers J C Rosendaal F R Lupus anticoagulants and the risk of a first episode of deep venous thrombosis J Thromb Haemost 2005 3 9 1993 1997
19. Galli M Luciani D Bertolini G Barbui T Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood 2003 101 5 1827 1832
20. Sciascia S Cosseddu D Montaruli B Kuzenko A Bertero M T Risk scale for the diagnosis of antiphospholipid syndrome Ann Rheum Dis 2011 70 8 1517 1518
21. Opatrny L David M Kahn S R Shrier I Rey E Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis J Rheumatol 2006 33 11 2214 2221
22. Pengo V Tripodi A Reber G, et al; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection J Thromb Haemost 2009 7 10 1737 1740
23. Lockshin M D Kim M Laskin C A, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies Arthritis Rheum 2012 64 7 2311 2318
24. Tincani A Balestrieri G Allegri F, et al. Overview on anticardiolipin ELISA standardization J Autoimmun 2000 15 2 195 197
25. Pengo V Ruffatti A Legnani C, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study Blood 2011 118 17 4714 4718
26. Abou-Nassar K Carrier M Ramsay T Rodger M A The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis Thromb Res 2011 128 1 77 85
27. Silver R M Parker C B Reddy U M, et al. Antiphospholipid antibodies in stillbirth Obstet Gynecol 2013 122 3 641 657
28. Simchen M J Dulitzki M Rofe G, et al. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome Acta Obstet Gynecol Scand 2011 90 12 1428 1433
29. Mekinian A Loire-Berson P Nicaise-Roland P, et al. Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels J Reprod Immunol 2012 94 2 222 226
30. Matsuura E Igarashi Y Yasuda T Triplett D A Koike T Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface J Exp Med 1994 179 2 457 462
31. Cabral A R Amigo M C Cabiedes J Alarcon-Segovia D The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays Am J Med 1996 101 5 472 481
32. Pierangeli S S Liu S W Anderson G Barker J H Harris E N Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies Circulation 1996 94 7 1746 1751
33. Jankowski M Vreys I Wittevrongel C, et al. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster Blood 2003 101 1 157 162
34. Ramesh S Morrell C N Tarango C, et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2 J Clin Invest 2011 121 1 120 131
35. Pierangeli S S Chen P P González E B Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms Curr Opin Hematol 2006 13 5 366 375
36. de Groot P G Derksen R H Pathophysiology of antiphospholipid antibodies Neth J Med 2004 62 8 267 272
37. Meroni P L Borghi M O Raschi E Tedesco F Pathogenesis of antiphospholipid syndrome: understanding the antibodies Nat Rev Rheumatol 2011 7 6 330 339
38. Rand J H Wu X X Guller S Scher J Andree H A Lockwood C J Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi Am J Obstet Gynecol 1997 177 4 918 923
39. Out H J Kooijman C D Bruinse H W Derksen R H Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies Eur J Obstet Gynecol Reprod Biol 1991 41 3 179 186
40. De Wolf F Carreras L O Moerman P Vermylen J Van Assche A Renaer M Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant Am J Obstet Gynecol 1982 142 7 829 834
41. Stone S Pijnenborg R Vercruysse L, et al. The placental bed in pregnancies complicated by primary antiphospholipid syndrome Placenta 2006 27 4-5 457 467
42. Derksen R H de Groot P G The obstetric antiphospholipid syndrome J Reprod Immunol 2008 77 1 41 50
43. Di Simone N Meroni P L de Papa N, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I Arthritis Rheum 2000 43 1 140 150
44. Girardi G Berman J Redecha P, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome J Clin Invest 2003 112 11 1644 1654
45. Girardi G Redecha P Salmon J E Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation Nat Med 2004 10 11 1222 1226
46. Shamonki J M Salmon J E Hyjek E Baergen R N Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies Am J Obstet Gynecol 2007 196 2 167.e1 167.e5
47. Ruiz-Irastorza G Crowther M Branch W Khamashta M A Antiphospholipid syndrome Lancet 2010 376 9751 1498 1509
48. Sneddon I B Cerebro-vascular lesions and livedo reticularis Br J Dermatol 1965 77 180 185
49. Cervera R Rodríguez-Pintó I Colafrancesco S, et al. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome Autoimmun Rev 2014 13 7 699 707
50. Regan L Braude P R Trembath P L Influence of past reproductive performance on risk of spontaneous abortion BMJ 1989 299 6698 541 545
51. RCOG The Investigation and Treatment of Couples with Recurrent First-trimester and Second-trimester Miscarriage Green-top Guideline No 17 2011
52. do Prado A D Piovesan D M Staub H L Horta B L Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis Obstet Gynecol 2010 116 6 1433 1443
53. Clark E AS Silver R M Branch D W Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 2007 9 3 219 225
54. Yamada H Atsumi T Kobashi G, et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes J Reprod Immunol 2009 79 2 188 195
55. van Hoorn M E Hague W M van Pampus M G Bezemer D de Vries J I; FRUIT Investigators. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT Eur J Obstet Gynecol Reprod Biol 2016 197 168 173
56. Rodger M A Langlois N J de Vries J I, et al. Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM) Syst Rev 2014 3 69
57. Keeling D Mackie I Moore G W Greer I A Greaves M; British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome Br J Haematol 2012 157 1 47 58
58. Cohen H Hunt B J Efthymiou M, et al; RAPS trial Investigators. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial Lancet Haematol 2016 3 9 e426 e436
59. Rai R Cohen H Dave M Regan L Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ 1997 314 7076 253 257
60. Laskin C A Spitzer K A Clark C A, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial J Rheumatol 2009 36 2 279 287
61. Kutteh W H Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone Am J Obstet Gynecol 1996 174 5 1584 1589
62. Farquharson R G Quenby S Greaves M Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment Obstet Gynecol 2002 100 3 408 413
63. Danza A Ruiz-Irastorza G Khamashta M Antiphospohlipid syndrome in obstetrics Best Pract Res Clin Obstet Gynaecol 2012 26 1 65 76
64. Bouvier S Cochery-Nouvellon E Lavigne-Lissalde G, et al. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study Blood 2014 123 3 404 413
65. Bramham K Hunt B J Germain S, et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome Lupus 2010 19 1 58 64
66. Bramham K Thomas M Nelson-Piercy C Khamashta M Hunt B J First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss Blood 2011 117 25 6948 6951
67. Dendrinos S Sakkas E Makrakis E Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome Int J Gynaecol Obstet 2009 104 3 223 225
68. Girardi G Can statins prevent pregnancy complications? J Reprod Immunol 2014 101-102 161 167
69. Ahmed A Singh J Khan Y Seshan S V Girardi G A new mouse model to explore therapies for preeclampsia PLoS ONE 2010 5 10 e13663
70. Redecha P van Rooijen N Torry D Girardi G Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury Blood 2009 113 17 4101 4109
71. clinicaltrials.gov Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery Available at https://clinicaltrialsgov/ct2/show/NCT02314286?term=rosuvastatin+pregnancy&rank=1 2016
72. Tektonidou M G Laskari K Panagiotakos D B Moutsopoulos H M Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies Arthritis Rheum 2009 61 1 29 36
73. Mekinian A Costedoat-Chalumeau N Masseau A, et al. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome? Autoimmun Rev 2015 14 1 23 29
74. Hunt B J A novel antiphospholipid antibody agent? Blood 2010 115 11 2124 2125
75. The Canadian Hydroxychloroquine Study Group A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus N Engl J Med 1991 324 3 150 154
76. Wallace D J Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus? Arthritis Rheum 1987 30 12 1435 1436
77. Morand E F McCloud P I Littlejohn G O Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis Ann Rheum Dis 1992 51 12 1318 1321
78. Kaplan Y C Ozsarfati J Nickel C Koren G Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis Br J Clin Pharmacol 2016 81 5 835 848
79. Flint J Panchal S Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice Rheumatology (Oxford) 2016
80. Flint J Panchal S Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids Rheumatology (Oxford) 2016
81. Espinola R G Pierangeli S S Gharavi A E Harris E N Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies Thromb Haemost 2002 87 3 518 522
82. Edwards M H Pierangeli S Liu X Barker J H Anderson G Harris E N Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice Circulation 1997 96 12 4380 4384
83. Rand J H Wu X X Quinn A S, et al. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug Blood 2010 115 11 2292 2299
84. Bertolaccini M L Contento G Lennen R, et al. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome J Autoimmun 2016
85. Chighizola C B Gerosa M Trespidi L, et al. Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome Expert Rev Clin Immunol 2014 10 11 1505 1517
86. Cantwell R Clutton-Brock T Cooper G, et al. Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom BJOG 2011 118 01 1 203
87. Gynaecologists RCoO Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium Green-top Guideline No 37a 2015
88. Espinoza J Kusanovic J P Bahado-Singh R, et al. Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension? J Ultrasound Med 2010 29 7 1103 1115
89. Hunt B J Missfelder-Lobos H Parra-Cordero M, et al. Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks J Thromb Haemost 2009 7 6 955 961